Description
| Product Name | CAT.No | Size |
| Brucella & Proteus +ve Control | FEPBPPC1 | 1 x 1ml |
| Brucella Abortus | FEBBAB05 | 1 x 5ml |
| Brucella Abortus | FEBBAB1L | 1000ml |
| Brucella Melitensis | FEBBME05 | 1 x 5ml |
| Brucella Melitensis | FEBBME1L | 1000ml |
Product Description
The Biorex Diagnostics Brucella Agglutination Test is a reliable serological assay designed for the qualitative and semi-quantitative detection of antibodies to Brucella abortus in human serum. Brucellosis, also known as undulant fever, is a significant zoonotic disease transmitted through direct contact with infected animals or the consumption of contaminated animal products such as unpasteurised milk and cheese. Early and accurate laboratory diagnosis is essential to ensure timely treatment, prevent complications, and support effective public health control measures.
This agglutination-based assay provides a rapid and dependable method for identifying immune responses associated with brucellosis. Its straightforward testing procedure and clear visual results make it well suited for use in clinical laboratories, hospitals, occupational health settings, and public health surveillance programmes, particularly in endemic regions.
Key Features
- High sensitivity and specificity – dependable detection of antibodies directed against Brucella abortus, supporting accurate diagnosis
- Rapid visual results – clear agglutination reactions visible to the naked eye within minutes
- Simple and efficient procedure – minimal laboratory equipment required, reducing hands-on time and training needs
- Ready-to-use reagents – supplied with standardised antigens, controls, and reagents to ensure consistent performance
- Versatile application – suitable for routine diagnostics, occupational screening, epidemiological surveys, and outbreak investigations
Benefits
Routine use of the Brucella Agglutination Test enables laboratories to identify suspected cases quickly, facilitating early clinical intervention and improved patient outcomes. The test also supports monitoring of antibody levels during treatment, helping clinicians assess therapeutic response and disease progression. Its rapid turnaround time enhances laboratory workflow efficiency while maintaining reliable and reproducible results.
From a public health perspective, this assay plays an important role in disease surveillance and control programmes, particularly in agricultural and veterinary-linked occupations where exposure risk is higher. The test’s affordability and ease of use make it especially valuable for large-scale screening initiatives and resource-limited settings.
The Biorex Diagnostics Brucella Agglutination Test combines simplicity, accuracy, and cost-effectiveness in a single diagnostic solution. Its proven performance and user-friendly design make it a trusted choice for laboratories seeking dependable serological testing for brucellosis, supporting improved patient care, occupational safety, and effective public health management.
Contact Us for more information.